Figure 1.

Crude risk of acquired immune deficiency syndrome (AIDS) (solid line) and death (dashed line, stacked) among 7,182 human immunodeficiency virus–positive adults from the Centers for AIDS Research Network of Integrated Clinical Systems who initiated antiretroviral therapy between 1998 and 2012. A) For non–injection drug users, B) for injection drug users.